APA (7th ed.) Citation

J, D., JC, T., A, P., EC, D., H, N., I, S. d. l. C., . . . M, P. (2022). Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: Results from a randomized, controlled, observer-blind study in adolescents and young adults. Human vaccines & immunotherapeutics, 18(1), 1981085. https://doi.org/10.1080/21645515.2021.1981085

Chicago Style (17th ed.) Citation

J, Díez-Domingo, et al. "Immunological Non-inferiority of a New Fully Liquid Presentation of the MenACWY-CRM Vaccine to the Licensed Vaccine: Results from a Randomized, Controlled, Observer-blind Study in Adolescents and Young Adults." Human Vaccines & Immunotherapeutics 18, no. 1 (2022): 1981085. https://doi.org/10.1080/21645515.2021.1981085.

MLA (9th ed.) Citation

J, Díez-Domingo, et al. "Immunological Non-inferiority of a New Fully Liquid Presentation of the MenACWY-CRM Vaccine to the Licensed Vaccine: Results from a Randomized, Controlled, Observer-blind Study in Adolescents and Young Adults." Human Vaccines & Immunotherapeutics, vol. 18, no. 1, 2022, p. 1981085, https://doi.org/10.1080/21645515.2021.1981085.